Telomere length maintenance in stem cell populations  by Allen, Nicholas D. & Baird, Duncan M.
Biochimica et Biophysica Acta 1792 (2009) 324–328
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbad isReview
Telomere length maintenance in stem cell populations
Nicholas D. Allen a, Duncan M. Baird b,⁎
a School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3, USA
b School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK⁎ Corresponding author. Tel.: +44 29 2068 7038; fax
E-mail address: bairddm@cardiff.ac.uk (D.M. Baird).
0925-4439/$ – see front matter © 2009 Elsevier B.V. A
doi:10.1016/j.bbadis.2009.02.004a b s t r a c ta r t i c l e i n f oArticle history: The maintenance of telome
Received 12 December 2008
Received in revised form 4 February 2009
Accepted 5 February 2009






Stem cellre length is essential for upholding the integrity of the genome. There is good
evidence to suggest that telomere length maintenance in stem cell populations is important to facilitate the
cell division required for tissue homeostasis. This is balanced against the requirement in long lived species for
proliferative life span barriers for tumour suppression; the gradual erosion of telomeres provides one such
barrier. The dynamics of telomeres in stem cell populations may thus be crucial in the balance between
tumour suppression and tissue homeostasis. Here we brieﬂy discuss our current understanding of telomere
dynamics in stem cell populations, and provide some data to indicate that telomeres in human embryonic
stem cells may be more stable and less prone to large-scale stochastic telomeric deletion.
© 2009 Elsevier B.V. All rights reserved.1. The importance of telomere length in stem cell populationsThe regenerative capacity of human tissues declines with age and
the incidence of cancers increases; both these processes may be
driven by a decline in stem cell function [1–5]. There has to be a
balance, in long-lived organisms such as humans, between maintain-
ing regenerative potential on one hand, and tumour suppression on
the other. Several studies focusing on p16INK4A, a key mediator of
replicative senescence, suggest that this may be the case. In the bone
marrow of mice, p16INK4A levels increase with age in haematopoietic
stem cells, but not in other cell types [6]; this correlated with a decline
as a function of age, in the ability of these cells to reconstitute the
immune system of irradiated mice, whereas p16INK4A−/− mice had
more stem cells and were better able to reconstitute an immune
system. Similar observations were made in neurons from the
forebrain, where again p16INK4A levels increased with age, which
correlated with a decline in proliferation, this was to some extent
ameliorated in p16INK4A−/− mice [7]. As p16INK4A is a tumour
suppressor, the deﬁciency of protein leads to an increased frequency
of cancer [8], and yet these data show that the absence of p16INK4A can
slow most aspects of stem cell ageing, thus highlighting the balance
between tumour suppression and regenerative capacity. This is likely
to result from multiple factors such as Bmi1 that promote prolifera-
tion, balanced against tumour suppression for example by p16INK4A
[9–11]. One mechanism that may contribute to ﬁne tune this balance
may be telomere length, whereby stem cells may need to maintain
telomeres at a length that provides sufﬁcient replicative capacity for: +44 29 2068 7343.
ll rights reserved.tissue homeostasis, versus the requirement to minimise telomere
length and replicative capacity as a tumour suppressive mechanism.
Telomere length is an important determinant of telomeric
function, in the presence of a functional DNA damage response
short telomeres elicit a DNA damage checkpoint, that leads to either
replicative senescence or apoptosis [12]. Telomere-dependent repli-
cative senescence represents the tumour suppressive function of
telomeres [13,14]; the corollary of which may be an age-related
accumulation of senescent cells [15,16]. The presence of senescent
cells not only reduces the proportion ofmitotically active cells butmay
also, but by virtue of exhibiting a more catabolic phenotype they can
actively degrade the tissue microenvironment [17]. Interestingly even
the presence of a small proportion of senescent cells, may render the
tissue microenvironment more permissive for tumour progression
[18]. The importance of telomere length from the standpoint of ageing
and cancer is exempliﬁed by the telomerase knock out mice. Where
after several generations telomeres erode sufﬁciently to confer a
phenotype, whereby the presence of short telomeres leads to defects
in proliferative tissues that mirror some age-related phenotypes in
humans. In addition to a shortened lifespan these include, immuno-
senescence, alopecia, hair greying and intestinal atrophy and
increased rate of tumour formation [19–22]. These phenotypes
could be partially rescued in the context of mutations in the DNA
damage checkpoint responses, for example the absence of p53
rescued some of the proliferative defects, but this was accompanied
by an increase in the rate of tumour formation [23]. Interestingly in
the context of Terc and p21 mutations, the rescue of age related
phenotypes was not accompanied by an increase in tumourigenesis,
despite rescuing proliferative and self renewal detects in stem cell
populations; these observations indicate that, p53/p21 dependent,
telomere driven, replicative senescence was driving the age-related
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protective [24]. Some of the phenotypes exhibited by the telomerase
knockout mice mirror those observed in individuals with dyskeratosis
congenita (DC): a disease characterised by mutations in genes that
result in impaired telomere length maintenance, such as components
of the telomerase complex that results in haploinsufﬁciency for
telomerase activity [25–27], or components of the shelterin complex
[28]. DC patients exhibit reduced haematopoiesis, reduced number of
haematopoietic progenitors and colony forming ability [29,30], and
chromosomal instability phenotypes [31,32]. In addition, like telo-
merase knockout mice, DC patients display disease anticipation,
whereby the severity and age of onset of the disease, get progressively
worse from one generation to the next [33]. Failure of telomere length
maintenance has been implicated in other bone marrow failure
syndromes including Fanconi anaemia, Shwachman–Diamond syn-
drome, Diamond–Blackfan anaemia and aplastic anaemia [34–37].
Thus clinical data together with mouse models indicate telomere
length maintenance is important in the context of human disease, the
ageing process and cancer; it appears likely that telomere length
maintenance in the stem cells compartments may play a crucial role in
these processes.
2. Telomere length dynamics in human stem cell populations
Data concerning telomere length and telomerase activity in stem
cells is limited. Adult stem cell populations undergo cell division
comparatively infrequently [38] and therefore, based on the end
replication problem, stem cells would be predicted to suffer limited
telomere erosion, irrespective of telomerase expression. The most
extensively studied stem cells are those of the haematopoietic system.
Haematopoietic stem cells (HSCs) are known to express telomerase
[39,40] yet they appear to be subjected to telomere loss as a function of
age [41]; telomerase activity is insufﬁcient tomaintain telomere length
in HSCs and thus the proliferative potential of these cells may decline
with age. However telomerase is up regulated following immune
stimulation of B and T cells [42–46], this is sufﬁcient to reduce the rate
of telomere erosion, and some cases result in telomere lengthening
[47–49]. Importantly the up regulation of telomerase activity following
stimulation, confers a proliferative lifespan extension compared to
cells that do not express telomerase, this allows for repeated clonal
expansions in response to the antigen [48]. However this is not
unlimited and ultimately telomere erosion and the loss of proliferative
potential may underlie some aspects of immunosenescence [49,50].
In the epidermis, telomerase is expressed by cells speciﬁcally on
the basal layer [51], yet telomere length decreases with age [52].
Spermatogonial stem cells express high levels of telomerase [53–55],
this is considered to maintain telomere length in the germline for
subsequent generations. Indeed to date the male germline is the only
tissue that has shown to exhibit telomere lengthening as a function of
age [56,57]. There is evidence to suggest that there is a gradient in
telomere length from the stem cell compartments which decreases in
more differentiated cell populations. This was exempliﬁed by the
lingual mucosa, where in situ hybridisation revealed the longest
telomeres in the basal cells [58]. Further evidence using in situ
methods in mice also showed distinct gradients of telomere length,
with the longest telomeres observed in the stem cell compartments of
the skin, small intestine, cornea, testis and brain [59]. Of particular
importance, this work included the observation that the telomere
length in the stem cell compartments appears to shorten with age
[59]. Thus the evidence from humans and mice, indicates that stem
cells maintain telomeres at a longer length, relative to the other cells
within the tissue in which they reside. This is probably a function of a
combination of telomerase activity together with a reduced cell
turnover. However, with the exception of spermatogonial stem cells,
some stem cell compartments have been shown to suffer telomere
erosion as a function of age.Telomerase activity is likely to be limiting inmost cells that express
telomerase at physiological levels. Over expression of the RNA and
protein components of telomerase individually does not result in
signiﬁcant telomere lengthening [60]. However when both compo-
nents are over expressed simultaneously, these super-telomerase cells
exhibit ongoing telomere lengthening with no apparent length
control. These data imply that in cells where telomere length is stable
telomerase levels are limiting; it is the shortest telomeres in the cells
that are preferentially lengthened [60,61]. This must require a ﬁne
balance in the levels of telomerase activity to maintain telomere
length; therefore subtly lower levels, such as may be observed in stem
cell compartments, could lead to gradual telomere erosion. Whether
telomere length would become limiting in this situation is unclear;
telomerase preferentially extends shorter telomeres [61] and thus
telomeres could erode to a new shorter, but stable state, as observed in
many cancer derived cell lines [60]. Furthermore mice that are
haploinsufﬁcient for either the RNA or protein components of
telomerase maintain telomeres at a shorter length but do not exhibit
obvious direct telomere defects, such as telomere fusion [62,63].
3. Telomere instability
Telomeres shorten primarily as a consequence of gradual end-
replication losses with ongoing cell division [64,65]. However more
detailed analysis of telomere dynamics in human cells has indicated
the existence of additional mechanisms that generate sporadic large-
scale changes in telomere length [66]. In normal human cells, rare
telomeres have been observed that lack signals from ﬂuorescently
labelled telomere repeat containing probes; these may arise as
consequence of sporadic large-scale telomeric deletion events
[67–69]. Using an experimentally transformed cell line carrying a
tagged chromosome end, Murnane et al. observed changes in
telomere length which appeared to have resulted from large-scale
telomere deletion events [70]; other types of events included the
deletion of the entire telomere and adjacent DNA coupled with
healing of the end, possibly by de novo telomere addition, or
chromosomal fusion events [71]. Interestingly these events occur in
cells that express telomerase and can maintain telomere length for
extended periods in culture, yet they can still suffer telomeric
instability. Single molecule PCR analysis of telomere length has
shown that in the absence of telomerase, gradual telomere erosion
results in a decrease in the mean and an increase in the variance of the
distribution [65,72]. These data are consistent with the telomere
dynamics predicted as a consequence of end-replication losses,
together with a putative C-strand resection [64,65]. However, super-
imposed on the gradual erosion of the bulk of the telomere length
distribution, were large-scale, apparently sporadic, telomere deletion
events. These events have been observed both in the presence or
absence of telomerase and can result in telomeres containing less than
20 TTAGGG repeats [72,73]. The occurrence of these deleted telomeres
is sporadic, and they do not accumulate with ongoing cell division.
This indicates that, either the cell inwhich the deletion event occurred
exited the cell cycle, or alternatively the deleted telomerewas not long
enough to confer telomeric function and was subjected to further
processing. Such telomeres could be repaired to full length or
subjected to telomere fusion. Indeed fusion analysis has revealed
that telomeres that had suffered a deletion event are subjected to
fusion [74]. Importantly in normal cells that contain a complement of
telomeres that are long and fully functional, rare fusion events are
detected that involve very short telomeres. These events are
consistent with the concept that normal cells can be subjected to
stochastic telomeric deletion, and these deleted telomeres can
undergo fusion. This implies that cells within normal tissues in vivo
may be subjected to telomeric deletion events, that can lead, via
anaphase bridging, breakage and fusion events, to large-scale,
potentially oncogenic mutation. This cell intrinsic mutational load
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mutations, where a telomere that had suffered a deletion event, can be
subjected to fusion, rather than causing the cell to exit the cell cycle.
Indeed there are clonal patches of keratinocytes within the epidermis,
that exhibit p53 mutations [75–77] and thus short dysfunctional
telomeres in these cells may exhibit a greater propensity to undergo
fusion than in keratinocytes with functional p53. These data indicate
that it will be informative to understand the dynamics of telomere
length in stem cell populations. To this end, we have some preliminary
data to suggest that at least some stem cell populations may exhibit a
greater degree of telomere stability compared to other cell types that
have been analysed. Fig. 1 shows an example of this data, where
human embryonic stem (hES) cells have been subjected to a large
scale single telomere length analysis. At the 17p and XpYp telomeres
the mean telomere length at both ends was broadly similar at 13.0
and12.8 kb respectively, this is within the range observed in the male
germline [56]. A bimodal distribution was apparent at the XpYp
telomere, which is consistent with the presence of two telomeric
alleles that are maintained at different lengths of 6.9 and 15 kb; a
telomere length differential of 8.1 kb. These data are consistent with
the concept that the telomere length setting of speciﬁc alleles, in the
presence of telomerase, may be determined by cis acting elements or
allele speciﬁc epigenetic modiﬁcations [73,78,79]. Telomere length of
the hES was heterogeneous with telomeres ranging from 3.0 kb to
over 25 kb. However it was striking that we could not observe a single
telomere out of a total sample of 753 molecules that was less than
3.0 kb (Fig. 1). In ﬁbroblast cell cultures sporadic telomere deletion
results in telomeres of less than 10 TTAGGG repeats at a frequency of
9×10−3; these are telomeres that have been shown to undergo fusionFig. 1. Telomere length analysis of the human embryonic stem cell line, HUES9. Large
scale analysis of telomere length at the XpYp and 17p telomeres using single telomere
length analysis (STELA). Telomere length statistics are shown below.[74]. Compared to these cells, the paucity of stochastic telomeric
deletion events in our sample of human embryonic stem cells is
signiﬁcant (Pb0.001, Chi sq.). These data indicate the possibility that
human embryonic stem cells may exhibit enhanced telomere stability.
Consistent with this view, whilst some human ES cells display
karyotypic changes following prolonged periods in culture, the
predominant aberrations are aneuploidy, speciﬁcally gains of chromo-
somes 17,12 and X, with less evidence of non-reciprocal translocations
that occur as a consequence of telomere dysfunction [80]. The
mechanisms underlying telomere deletion events is not clear [81],
but may include mechanisms such as T-loop recombination [68,82],
unequal sister chromatid exchange [83], replication slippage, or
resolution of stalled replication forks at sites of unrepaired damage
or DNA structures, such as G-quartets, that cannot be replicated [84].
Thus the mechanism by which human embryonic stem cells may
exhibit enhanced telomeric stability is also not clear, however in this
context it is pertinent to note that these cells exhibit enhanced
genomic maintenance in humans [85], and lower levels of reactive
oxygen species in mice [86,87]. DNA damage, including that generated
by oxidative stress, may provide an obstacle to telomeric replication,
the resolution of which could initiate large-scale changes in telomere
length. Adult stem cells may not exhibit the same levels of genomic
stability compared to embryonic stem cells; it will therefore be
informative to understand how levels of telomeric stability differ
between these cell types.
4. Chromatin structure and genomic organisation in stem cells
If the apparent stability of telomeres in hES cells, and indeed other
stem cell types, is borne out by further analysis, the mechanistic basis
of telomeric stability would warrant investigation. In addition to the
enhanced levels of DNA repair one could speculate that telomeric
stability could be related to differences in chromatin distributions
and/or differences in nuclear organisation. The organisation of loci
within the nucleus can regulate transcription, with different cell types
displaying distinct nuclear organisation patterns [88,89]. Stem cells
are no exception, as they display a nuclear architecture, such that loci
required for the maintenance of pluripotency, display speciﬁc nuclear
locations; for example NANOG on 12p has a more central location in
ES cells compared to differentiated cells, or 6p that maintains its
chromosome position but the OCT4 locus on that chromosome is
outside of its usual position [90]. It is known from studies in yeast that
the tethering of telomeres at the nuclear periphery is important to
regulate transcription of telomere associated genes such as the
mating-type loci [91], which may be mediated by regulating the
telomeric chromatin [91]. It also appears that embryonic stem cells
exhibit a distinct chromatin structure, that is important for controlling
the expression proﬁles required to maintain pluripotency [92–95]. ES
cells are uniquely characterised by a prevalence of a bivalent
chromatin state, in which many developmentally regulated genes
simultaneously possess both activating and silencing epigenetic
chromatinmodiﬁcations [96].Whether these differences in chromatin
extend to the telomeres is not clear. It is becoming apparent that
the chromatin status of telomeres, which exhibit epigenetic marks
of compacted heterochromatin, can control telomeric stability
[78,79,97,98]. For example in mice the subtelomeric regions are
heavily methylated, but mammalian telomere repeats lack the CpG
sites for methylation. Interestingly the knockout of DNA methyltrans-
ferases results in large-scale changes in telomere length, that may be
associated with increased recombinational activity including sister
chromatid exchange [98]. Thus chromatin structure contributes to
telomeric stability, and speciﬁc chromatin patterns in stem cells may
confer enhanced telomere length stability.
In summary, telomere length in stem cell populations is an
important determinant of the replicative potential that is required for
tissue homeostasis, yet telomere length may decline as a function of
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combination of stem cell turnover and limiting levels of telomerase,
possibly also with enhanced telomere stability. More studies of
telomere length dynamics in human stem cells are required for us
to fully understand the role that telomeres may play in stabilising the
genomes of these cells and how this may relate to the age-related
deterioration in stem cell function.
5. Human ES cell culture
The hESC line HUES9 (hES facility; Harvard University, Cambridge,
MA, USA) derived in accordance with local and national guidelines
was used. hESCs were cultured and passaged on a layer of irradiated
mouse embryonic ﬁbroblasts at a density 1×106 cells/60 mm dish
and passaged by enzymatic and mechanical means [99]. To remove
contaminating feeder cells prior to DNA extraction, hESCs were ﬁrst
passaged twice onto matrigel coated plates (BD Biosciences; Oxford
UK; http://www.bdeurope.com) with feeder conditioned culture
medium. Culture medium (KSR) consisted of Knockout Dulbecco's
Modiﬁed Eagle'sMedium (KO-DMEM) supplementedwith 20% Serum
Replacement, 1% Non-Essential Amino Acids, 1 mM L-Glutamine,
0.1 mM β-mercaptoethanol (all from Invitrogen; Carlsbad, CA, USA;
http://www.invitrogen.com) and 10 ng/ml human FGF2 (R and D
systems; Minneapolis, MN, USA; http://www.rndsystems.com).
6. DNA extraction and single telomere length analysis
DNA was extracted by standard phenol chloroform proteinase K
method as described previously [72]. Single telomere length analysis
was undertaken at theXpYp and17p telomeres as described previously
[74]. Each telomere was analysed using 18 reactions each containing
approximately 21 telomeric molecules.
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